Fetal Alcohol Spectrum Disorder in Adults: Health and Neurobehavior

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3U01AA026108-04S2

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2017
    2022
  • Known Financial Commitments (USD)

    $141,308
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Claire D Coles
  • Research Location

    United States of America
  • Lead Research Institution

    Emory University
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Other

  • Occupations of Interest

    Unspecified

Abstract

The 5-year award, for which this would be an administrative supplement in response to NOT-AA-20-011,focuses on the impact of prenatal alcohol exposure (PAE) on physical and mental health within the contextof social and environmental factors that may contribute to outcomes in adulthood. There are two important,and related, reasons to include attention to COVID-19 and the medical and social implications of thepandemic in this ongoing study of alcohol-affected adults. First, there is evidence that the adults in thelongitudinal cohorts being followed in Atlanta and Seattle are particularly vulnerable to the impact of thepandemic. Second, given this vulnerability, the pandemic represents a historic threat to the validity of studyoutcomes that must be addressed. In the parent study, 500 volunteers, half from each site will be seen forTier 1, that includes remote collection of self-reported health and demographic information. In Tier 2, 240individuals are being seen for more comprehensive assessment of health risk, immune status,neurocognition, and social functioning. To date, 226 individuals have completed Tier 1. Preliminary data,from Years 1-3, indicates that, in these samples, PAE is associated with higher risk for cardiovascularcompromise, intellectual and social dysfunction, and higher rates of substance use. The majority ofindividuals in these cohorts are from populations that have been identified nationally as more impacted byCOVID-19 infection and mortality (i.e., African-American; Native-American) and many in these groupsare highly anxious about the effects of the virus. Given these factors, we will collect information on theimpact of COVID-19 on health (e.g..,medical records), social outcomes (e.g., job loss, homelessness), andmental health status as well as substance use. COVID-relevant questionnaires will be administeredremotely to both those who have previously participated and to future participants allow measurement ofthe effects of the pandemic on these outcomes. In Atlanta only, an extra tube of blood will be obtainedduring existing blood draw for antibody testing. Finally, we will employ the National Death Index (NDI)to determine mortality rates over the past 10 years in the parent cohorts from which these samples are beingdrawn, allowing an estimate of mortality in these 902 individuals who have previously participated inresearch. We anticipate that individuals with PAE will show more impact on health during this emergencyand they may have a higher mortality rate than nonexposed individuals. Further, we anticipate that PAEwill be associated with greater anxiety related to COVID-Exposure and increased substance use. We alsohypothesize that social and environmental factors will contribute to the severity of effects.